The overarching aim of the GF Resilient & Sustainable Systems for Health RSSH project is to improve the health and well-
being of the Nigerian people by identifying and addressing systemic issues affecting the optimal delivery of health services in Nigeria.
The resulting high-level interventions have been designed to follow the Global Fund’s framework for RSSH that is built on the essential building blocks of WHO for a well-
functioning health system, including community systems strengthening (CSS) as another critical component to be addressed in support of RSSH.
The RSSH grant is designed to strengthen the Nigerian health system across the HIV, TB, and Malaria program areas. In doing so it'll have interventions targeted at the HMIS, PSM & Lab system strengthening areas.
There's also the additional dimension of the innovative "State approach" to be piloted in the three states of Oyo, Kaduna & Imo.
The state approach covers elements like public financial management, support for health insurance and health sector coordination among others.
Laboratory system strengthening aims to improve laboratory operations for optimal patient care, treatment, disease surveillance and response, biosafety and policy development.
To achieve this an enabling policy environment is required with a National Medical Laboratory Strategic Plan creating a road map for implementation of activities aimed at providing optimal laboratory services in Nigeria.
The Nigeria Medical Laboratory Services Policy was developed, between 2005 and 2007, to bridge the obvious gaps in the standards of operation of the medical laboratory, in its bid to provide to all Nigerians, appropriate, cost effective and high-
quality laboratory services. To ensure realization of this vision, a five year National Medical Laboratory Strategic Plan (NMLSt.
P) (2015 2019) was developed to provide road map for the operation of the medical laboratory services in Nigeria. This year, 2019 marks the end of the plan.
It is, therefore, important to evaluate that plan and use the evaluation outcome as a platform for the development of a new strategic plan to cover the period 2020 -2024.
Coverage / Scope (WHERE and WHEN) :
Two consultants will be required to work on the documents between the periods July to December 2019, a lead consultant and a costing consultant.
The lead consultant will be engaged for two consultancy activities for a period of 30 working days each disaggregated within the specified timeframe :
The second consultant will be a health economist who will be hired to cost the new NMLSt.P 2020 -2024 when completed.
The consultants will be required to engage key stake holders (such as NCDC, Medical Laboratory Science Council of Nigeria (MLSCN), Federal Ministry of Health, Medical and Dental Council of Nigeria (MDCN), NLTWG and others as deemed fit in the health sector with emphasis on medical laboratory practice in Nigeria.
This is essential for the development the new National Medical Laboratory Strategic Plan.
Implementation Approach (HOW) :
Reporting / Means of Verification / Deliverables :
Specific Scope of Work for Consultants
The key objectives for this short-term consultancy is to
Specific Terms of Reference
P within the five-year period.Provide comprehensive report of the consultancy
Expected completion Period : Consultancy will span the period July December 2019
Estimated level of effort : 30 days each.
Role of SR
Role of Consultants :
Qualifications and Experience
Required qualifications :
Role of MSH (RSSH) : Background Information
Management Sciences for Health (MSH), a global health nonprofit organization, uses proven approaches developed over 40 years to help leaders, health managers, and communities in developing nations build stronger health systems for greater health impact.
We work to save lives by closing the gap between knowledge and action in public health. Since its founding in 1971, MSH has worked in over 150 countries with policy makers, health professionals, and health care consumers to improve the quality, availability and affordability of health services.
tuberculosis; malaria; maternal, newborn and child health; family planning and reproductive health; and chronic non-communicable diseases such as cancer, diabetes, and lung and heart disease.
Through strengthening capacity, investing in health systems innovation, building the evidence base, and advocating for sound public health policy, MSH is committed to making a lasting difference in global health.